Dueling Records: Are Statements in Your 510(k) Putting Your Patents at Risk?
28 October 2015
Attorneys Jolene Fernandes, James Ewing, Lisamarie Collins, Jacki Lin and Linda Wu contributed an article to Bloomberg BNA’s Medical Devices Law & Industry Report, “Dueling Records: Are Statements in Your 510(k) Putting Your Patents at Risk?,” on October 28, 2015. The article laboratory developed test (LDT) providers and new U.S. Food and Drug Administration (FDA) oversight that requires LDTs providers to consider if their LDTs constitute moderate-risk or high-risk devices subject to FDA oversight. The article reviews emerging areas of regulation for LDT providers; 510(k) statements and real world consequences to patent assets; and practical solutions for mitigating risk.
Author(s)
Related Insights
29 April 2024
Labor & Employment Law Perspectives
DOL Increases Compensation Threshold for Exempt Employees
Starting July 1, 2024, employers must satisfy a higher salary threshold in order to consider employees as exempt from Fair Labor Standards Act overtime rules.
29 April 2024
Labor & Employment Law Perspectives
PWFA Final Rule is Now Published — It Takes Effect June 18, 2024
On April 15, 2024, the Equal Employment Opportunity Commission published a final rule to implement the Pregnant Workers Fairness Act (PWFA)
29 April 2024
Health Care Law Today
2024 Health Care & Life Sciences Top Trends
Foley & Lardner’s 2024 Health Care & Life Sciences Top Trends publication unpacks fast-moving developments to help your business.